Puradelta Lestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 11.3× UBC Medical Indonesia Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 817.3K). Which is the better fit depends on your goals.
| DMAS | LABS | |
|---|---|---|
Market Cap | 6.6T | 584.6B |
Volume | 40.24M | 817.3K |
Lot | 402.39K | 8.17K |
Turnover | 5.52B | 120.01M |
Average Price | 137.3 | 146.84 |
Value | 5.52B | 120.01M |
Indicative Equilibrium Price | 137 | 146 |
Indicative Equilibrium Volume | 9.27K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →